CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Telmisartan / Amlodipine

Last Updated: July 9, 2010
Result type: Reports
Project Number: SR0207-000
Product Line: Reimbursement Review

Generic Name: Telmisartan / Amlodipine

Brand Name: Twynsta

Manufacturer: Boehringer Ingelheim (Canada) Ltd

Therapeutic Area: Hypertension

Indications: Hypertension, Essential

Submission Type: Initial

Project Status: Cancelled